Cost-effectiveness of MRE versus VCTE in staging fibrosis for nonalcoholic fatty liver disease (NAFLD) patients with advanced fibrosis
Kinpritma Sangha 1, Stephanie T Chang 2 3, Ramsey Cheun…
Global and national prevalence of nonalcoholic fatty liver disease in adolescents: an analysis of the global burden of disease study 2019
Phillipp Hartmann 1 2, Xinlian Zhang 3, Rohit Loomba 4 …
SGLT2i reduces risk of developing HCC in patients with co-existing T2D and CHB infection – A territory-wide cohort study in Hong Kong
Chi-Ho Lee 1 2, Lung-Yi Mak 1 3, Eric Ho-Man Tang 4, Da…
Lactulose therapy for patients with cirrhosis, portal hypertension, and poor patient reported outcomes – the Mi-Kristal RCT
Elliot B Tapper 1, Erin Ospina, Najat Salim, Xi Chen, S…
Use of HBV RNA and hepatitis B core-related antigen to predict change in serological status and disease activity in CHB
Marc G Ghany 1, Wendy C King 2, Ama…
Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study
Daniel Q Huang 1, Laura A Wilson 2, Cynthia Behling 3, …